Suggestion de sujets dans votre recherche.
Résultat(s) 1 - 20 résultats de 113 pour la requête '', Temps de recherche: 2,99s Affiner les résultats
  1. 1
    Unlocking the Chemical Diversity of Plant Catharanthus roseus Nuclear Magnetic Resonance Spectroscopy Approach

    Article en ligne

  2. 2
    Comparative role of oxidative balance, alkaloid production, and metabolites in exposure to red-to-blue light in Catharanthus roseus

    Article en ligne

  3. 3
    Establishment of recombinant Catharanthus roseus stem cells stably overexpressing ORCA4 for terpenoid indole alkaloids biosynthesis

    Article en ligne

  4. 4
    Blood from a "half-fish" dog How modern analyzers deal with nucleated red blood cells

    Article en ligne

  5. 5
    A case of effective neoadjuvant chemotherapy (MVEC) against right ureteral cancer involving bladder (cT4N1M0)
    Article

  6. 6
    Relative efficacy of neoadjuvant gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management for muscle-invasive bladder cancer
    Article

  7. 7
    A case of primary urotherial carcinoma with glandular differentiation of the renal pelvis with high serum level of carbohydrate antigen 19-9 (CA19-9)
    Article

  8. 8
    Spatial organization of the vindoline biosynthetic pathway in Catharanthus roseus

    Article en ligne

  9. 9
    A case of primary urothelial carcinoma of the prostate responsive to MVAC intra-arterial chemotherapy a case report
    Article

  10. 10
    Annular rectal constriction caused by infiltrating bladder carcinoma a case report
    Article

  11. 11
    Squamous cell carcinoma of the renal pelvis with elevation of G-CSF in the serum a case report
    Article

  12. 12
    Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma
    Article

  13. 13
    Possible survival benefit of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin combination therapy (HD-MVAC) over conventional MVAC in metastatic urothelial carcinoma patients
    Article

  14. 14
    Adverse events of MVAC chemotherapy in patients with advanced urothelial cancer of the bladder
    Article

  15. 15
    Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation
    Article

  16. 16
    Second-line chemotherapy with gemcitabine and cisplatin for urothelial cancer previously treated with or resistant to M-VAC therapy
    Article

  17. 17
    Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy a case report
    Article

  18. 18
    Intra-arterial chemotherapy for invasive bladder cancer (T2-3N0M0)
    Article

  19. 19
    Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer
    Article

  20. 20
    Pyogenic spondylitis by methicillin-resistant Staphylococcus aureus (MRSA) during M-VAC therapy a case report
    Article

Outils de recherche: S'abonner aux flux RSS — Envoyer cette recherche par courriel